The hottest sectors in 2025 are loud: semiconductors, AI, defense tech. But behind the noise, health insurance providers are quietly expanding margins, scaling services, and outperforming the broader healthcare sector. They’re not the flashiest plays, but they may be the smartest long-term bets.
Health insurers like UnitedHealth Group, Cigna, and Elevance Health are built to weather volatility. Their business model relies on predictable cash flows from premiums, paired with careful risk management on claims. It’s a model that thrives even when macro conditions falter.
But what’s changing now is their proactive approach to growth. These companies aren’t just reacting to market pressure. They’re buying up clinics, expanding pharmacy benefit divisions, and integrating mental health offerings. UnitedHealth’s Optum arm, for example, now generates more revenue than many hospitals — and it’s growing faster.
Medicare Advantage Is the Powerhouse No One Talks About
While politicians and Wall Street focus on broader entitlement reform, Medicare Advantage enrollment keeps surging. Nearly 50% of Medicare-eligible Americans are now in MA plans — a figure that’s doubled over the last decade. And insurers have built increasingly tailored offerings, often wrapped with dental, vision, and wellness perks that traditional Medicare doesn’t offer.
This isn't just about better benefits. It's about locking in recurring revenue. Every new MA customer is another stream of federally backed income. And with boomers retiring in droves, this pipeline isn’t slowing.
Investors often shy away from healthcare due to the specter of regulation. That’s valid — but in the insurance space, the rules are known quantities, and large providers are already adept at navigating them. Minimum loss ratio thresholds, reimbursement caps, and rate setting timelines are baked into the business model.
What’s more, large insurers often help shape regulation, working with CMS and state agencies to adjust frameworks over time. This isn’t a corner of healthcare that gets blindsided easily.
Over the past year, multiples on health insurers have expanded, but still sit below peak levels from 2020–21. That’s left room for upside, especially as inflation cools and claims normalize. Meanwhile, their dividends and buyback programs continue to grow — attractive traits in a market with limited places to hide.
History backs the play. Since the early 2000s, managed care stocks have consistently outpaced the S&P 500, especially during economic slowdowns. They don’t get the glory, but they get the job done.
Disclaimer
We are not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authorities. Further, our owners, employees, agents are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authorities.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of our websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Disclaimer: Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and our partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing herein constitutes a recommendation respecting the particular security illustrated.